SCHEMBL21281487

SCHEMBL21281487

N=C(Cc1ccncc1)N1CCN(c2ccc3ccn(CCN4CCCC4)c3n2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ PARP1 P09874 3/20 0.36
▸ PIK3CA P42336 2/20 0.35
▸ MTOR P42345 2/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP4 P49662 1/20 0.35
▸ CASP5 P51878 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NOS3 P29474 2/20 0.32
▸ NOS1 P29475 2/20 0.32
▸ LTA4H P09960 1/20 0.32
▸ NOS2 P35228 1/20 0.32
▸ HTR1A P08908 2/20 0.31
▸ HTR2A P28223 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21273999 0.82 SMN1; SMN2 (0.53) PARP1PIK3CAMTORKDM4EALDH1A1
SCHEMBL21274001 0.82 CHKA (0.43) TDP1L3MBTL1HRH3CYP1A2CYP3A4
SCHEMBL21274094 0.79 PARP1 (0.50) PARP1HTR7
SCHEMBL22802004 0.78 PARP1 (0.46) L3MBTL1HRH3PARP1KDM4EALDH1A1
SCHEMBL21281583 0.78 PARP1 (0.51) HRH3PARP1NOS3NOS1NOS2
SCHEMBL21274069 0.77 PARP1 (0.52) HRH3CYP1A2PARP1KDM4EALDH1A1
SCHEMBL21281486 0.76 PARP1 (0.36) HRH3PARP1NOS3NOS1NOS2
SCHEMBL21274474 0.74 PIM1 (0.44) HRH3PARP1PIK3CAMTORALDH1A1
SCHEMBL21274287 0.74 KCNH2 (0.45) PARP1ALDH1A1HTR1AHTR2ADRD2
SCHEMBL21268791 0.73 HTR3E (0.43) TDP1HRH3CYP1A2CYP3A4PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3527209-A1 PHARMACEUTICAL 6,5 HETEROBICYCLIC RING DERIVATIVES UCB Biopharma SPRL (BE) 2019-08-21 — — EP disclosed
Send feedback